proxyvotesnow.com

Home › Companies › BIO-TECHNE CORP. › 2023-2024

BIO-TECHNE CORP. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and BIO-TECHNE CORP.’s Form 8-K, filed 2023-10-31 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 21Reported items
  • 580Asset managers
  • 9,774Fund votes
  • 2023-10-26Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BIO-TECHNE CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by BIO-TECHNE CORP.

These tallies are BIO-TECHNE CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2023-10-31 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIO-TECHNE CORP. — official shareholder meeting results, meeting held 2023-10-26
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Proposal 1: The shareholders voted to set the number of directors at nine: 141,242,833672,91934,066 ---- Majority: yes
Elect Director: Robert V. Baumgartner 100,149,01341,734,41566,390 --4,068,045 Majority: yes
Elect Director: Julie L. Bushman 132,251,0879,638,36960,362 --4,068,045 Majority: yes
Elect Director: John L. Higgins 116,991,41624,891,09467,308 --4,068,045 Majority: yes
Elect Director: Joseph D. Keegan 134,547,6667,343,70158,451 --4,068,045 Majority: yes
Elect Director: Charles R. Kummeth 139,037,6622,847,75664,400 --4,068,045 Majority: yes
Elect Director: Roeland Nusse 136,502,0965,384,16463,558 --4,068,045 Majority: yes
Elect Director: Alpna Seth 134,785,9527,102,98560,881 --4,068,045 Majority: yes
Elect Director: Randolph C. Steer 116,461,35725,398,61389,848 --4,068,045 Majority: yes
Elect Director: Rupert Vessey 134,555,0987,335,53459,186 --4,068,045 Majority: yes
Proposal 3: The shareholders voted against a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement: 49,894,29591,277,734777,789 --4,068,045 Majority: no
Proposal 5: The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024. 140,734,6765,247,72135,466 ---- Majority: yes

Source: BIO-TECHNE CORP., Form 8-K, filed with the SEC on 2023-10-31 — read the filing on EDGAR.

How asset managers voted at the BIO-TECHNE CORP. 2023-2024 meeting

Each item below shows how the 580 asset managers that disclosed a BIO-TECHNE CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIO-TECHNE CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: no

Combines 5 wordings of this item as funds reported it.

35% Majority: no · of votes cast

FOR 35%AGAINST 65%
FOR: 49,894,295AGAINST: 91,277,734

BIO-TECHNE CORP.’s own tally for this item (“Proposal 3: The shareholders voted against a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 49,894,295 for, 91,277,734 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 32% for, 58% against (89% of the company cast a for/against vote).

The 526 asset managers below cast 29% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 29%AGAINST 70%
FOR: 29.3%AGAINST: 70.4%ABSTAIN: 0.3%NOT VOTED: 0.0%1 YEAR: 0.0%UNKNOWN: 0.0%
Largest asset managers voting on “APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR EXECUTIVE OFFICERS.” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard18,442,2011,462,345 00For
BlackRock52,37914,454,611 00Against
WisdomTree32,62611,058,577 00Against
Lazard011,000,000 00Against
Fidelity6,884,079266,745 00For
T. Rowe Price6,347,614449,205 00For
Neuberger Berman06,079,023 00Against
State Street05,403,174 00Against
BAMCO INC /NY/04,920,806 00Against
Select Equity Group, L.P.4,511,8830 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)04,464,944 00Against
GEODE CAPITAL MANAGEMENT, LLC3,588,2670 00For
Invesco03,163,563 00Against
DF DENT & CO INC3,102,5300 00For
Charles Schwab02,809,775 00Against
Thrivent02,615,283 00Against
Columbia Threadneedle02,354,577 00Against
American Century02,282,908 00Against
MACKENZIE FINANCIAL CORP02,261,875 00Against
Wellington02,215,152 00Against
BROWN CAPITAL MANAGEMENT LLC02,200,587 00Against
ATLANTA CAPITAL MANAGEMENT CO L L C02,076,026 00Against
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC02,004,751 00Against
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds01,843,654 00Against

Showing the 25 largest of 526 asset managers. See all 526 in the interactive database.

2. Approve, on an advisory basis, the frequency of advisory votes on executive compensation to occur every (1) year

SECTION 14A SAY-ON-PAY VOTESSECTION 14A SAY-ON-PAY VOTES

Combines 5 wordings of this item as funds reported it.

98% fund support · no official result

1 YEAR 84%10%

The 296 asset managers below cast 98% of the shares they voted on this item FOR (360,113 for, 6,473 against).

FOR: 360,113 (0.8%)AGAINST: 6,473 (0.0%)ABSTAIN: 79,294 (0.2%)1 YEAR: 38,032,239 (84.3%)1: 4,511,996 (10.0%)ONE YEAR: 2,013,347 (4.5%)3 YEARS: 115,562 (0.3%)NOT VOTED: 7,323 (0.0%)TWO YEARS: 113 (0.0%)3 YEAR: 16 (0.0%)
Largest asset managers voting on “Approve, on an advisory basis, the frequency of advisory votes on executive compensation to occur every (1) ye” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Neuberger Berman00 001 Year
Select Equity Group, L.P.00 001
DF DENT & CO INC00 001 Year
Charles Schwab00 001 Year
MACKENZIE FINANCIAL CORP00 001 Year
Wellington00 001 Year
BROWN CAPITAL MANAGEMENT LLC00 001 Year
TRUST FOR PROFESSIONAL MANAGERS00 001 Year
Brown Capital Management Mutual Funds00 001 Year
Hartford00 001 Year
Advisors' Inner Circle Fund II00 001 Year
ArrowMark Colorado Holdings LLC00 001 Year
MARSHALL WACE, LLP00 001 Year
Northern Trust00 001 Year
RIVERBRIDGE PARTNERS LLC00 001 Year
Champlain Investment Partners, LLC00 001 Year
MAIRS & POWER INC00 001 Year
NEW YORK STATE COMMON RETIREMENT FUND00 001 Year
Vanguard00 00One Year
Bridge Builder Trust00 001 Year
CARILLON SERIES TRUST00 001 Year
FORUM FUNDS00 001 Year
Nationwide00 00One Year
AMERICAN CAPITAL MANAGEMENT INC00 001 Year
TOUCHSTONE STRATEGIC TRUST00 001 Year

Showing the 25 largest of 296 asset managers. See all 296 in the interactive database.

3. Approve, on an advisory bass, the frequency of advisory votes on executive compensation to occur every (1) year.

SECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

14% fund support · no official result

ONE YEAR 99.1%

The 243 asset managers below cast 14% of the shares they voted on this item FOR (32,800 for, 194,747 against).

FOR: 32,800 (0.0%)AGAINST: 194,747 (0.1%)ONE YEAR: 134,862,817 (99.1%)THREE YEARS: 540,511 (0.4%)1 YEAR: 411,961 (0.3%)1-YEAR: 27,978 (0.0%)
Largest asset managers voting on “Approve, on an advisory bass, the frequency of advisory votes on executive compensation to occur every (1) yea” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00One Year
BlackRock00 00One Year
WisdomTree32,6260 00One Year
Lazard00 00One Year
Fidelity00 00One Year
T. Rowe Price00 00One Year
State Street00 00One Year
BAMCO INC /NY/00 00One Year
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)00 00One Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
Invesco00 00One Year
Thrivent00 00One Year
Columbia Threadneedle00 00One Year
American Century00 00One Year
ATLANTA CAPITAL MANAGEMENT CO L L C00 00One Year
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC00 00One Year
Eaton Vance00 00One Year
Allspring00 00One Year
Waddell & Reed00 00One Year
Jackson Square Partners, LLC00 00One Year
Clearbridge Investments, LLC00 00One Year
MELLON INVESTMENTS Corp00 00One Year
FRED ALGER MANAGEMENT, LLC00 00One Year
BNY Mellon00 00One Year
JANUS INVESTMENT FUND00 00One Year

Showing the 25 largest of 243 asset managers. See all 243 in the interactive database.

4. Election of Directors: Alpna Seth

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 134,785,952AGAINST: 7,102,985

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Alpna Seth”): 134,785,952 for, 7,102,985 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 85% for, 4% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 99% of the shares they voted on this item FOR (89,011,636 for, 1,016,475 against).

FOR 99%
FOR: 89,011,636 (98.9%)AGAINST: 1,016,475 (1.1%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “Election of Directors: Alpna Seth” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.1,476,4030 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS0735,794 00Against
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

5. Election of Directors: Charles R. Kummeth

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 139,037,662AGAINST: 2,847,756

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Charles R. Kummeth”): 139,037,662 for, 2,847,756 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 88% for, 2% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (89,946,110 for, 82,001 against).

FOR 99.8%
FOR: 89,946,110 (99.9%)AGAINST: 82,001 (0.1%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “Election of Directors: Charles R. Kummeth” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.1,476,4030 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

6. Election of Directors: John L. Higgins

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST 18%
FOR: 116,991,416AGAINST: 24,891,094

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: John L. Higgins”): 116,991,416 for, 24,891,094 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 74% for, 16% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 88% of the shares they voted on this item FOR (78,792,307 for, 11,235,804 against).

FOR 88%12%
FOR: 78,792,307 (87.5%)AGAINST: 11,235,804 (12.5%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “Election of Directors: John L. Higgins” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock09,533,684 00Against
Fidelity5,215,71683,037 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.1,476,4030 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS0735,794 00Against
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

7. Election of Directors: Joseph D. Keegan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 134,547,666AGAINST: 7,343,701

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Joseph D. Keegan”): 134,547,666 for, 7,343,701 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 85% for, 5% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 85% of the shares they voted on this item FOR (76,781,624 for, 13,246,487 against).

FOR 85%AGAINST 15%
FOR: 76,781,624 (85.3%)AGAINST: 13,246,487 (14.7%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “Election of Directors: Joseph D. Keegan” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.1,476,4030 00For
Charles Schwab01,400,493 00Against
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon641,64536,926 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

8. Election of Directors: Julie L. Bushman

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 132,251,087AGAINST: 9,638,369

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Julie L. Bushman”): 132,251,087 for, 9,638,369 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 84% for, 6% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 85% of the shares they voted on this item FOR (76,710,713 for, 13,317,398 against).

FOR 85%AGAINST 15%
FOR: 76,710,713 (85.2%)AGAINST: 13,317,398 (14.8%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “Election of Directors: Julie L. Bushman” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.01,476,403 00Against
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon641,64536,926 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

9. Election of Directors: Randolph Steer

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

82% Majority: yes · of votes cast

FOR 82%AGAINST 18%
FOR: 116,461,357AGAINST: 25,398,613

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Randolph C. Steer”): 116,461,357 for, 25,398,613 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 74% for, 16% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 74% of the shares they voted on this item FOR (66,520,686 for, 23,507,425 against).

FOR 74%AGAINST 26%
FOR: 66,520,686 (73.9%)AGAINST: 23,507,425 (26.1%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “Election of Directors: Randolph Steer” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock09,533,684 00Against
Fidelity5,215,71683,037 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.1,476,4030 00For
Charles Schwab01,400,493 00Against
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon641,64536,926 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

10. Election of Directors: Robert V. Baumgartner

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

71% Majority: yes · of votes cast

FOR 71%AGAINST 29%
FOR: 100,149,013AGAINST: 41,734,415

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Robert V. Baumgartner”): 100,149,013 for, 41,734,415 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 63% for, 26% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 66% of the shares they voted on this item FOR (59,369,181 for, 30,658,930 against).

FOR 66%AGAINST 34%
FOR: 59,369,181 (65.9%)AGAINST: 30,658,930 (34.1%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “Election of Directors: Robert V. Baumgartner” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock09,533,684 00Against
Fidelity5,215,71683,037 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle02,340,399 00Against
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street01,608,405 00Against
Invesco1,553,2200 00For
Ownership Capital B.V.01,476,403 00Against
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed01,256,313 00Against
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS0735,794 00Against
BNY Mellon0678,571 00Against
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

11. Election of Directors: Roeland Nusse

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 136,502,096AGAINST: 5,384,164

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Roeland Nusse”): 136,502,096 for, 5,384,164 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 86% for, 3% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (89,943,233 for, 84,878 against).

FOR 99.8%
FOR: 89,943,233 (99.9%)AGAINST: 84,878 (0.1%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “Election of Directors: Roeland Nusse” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.1,476,4030 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

12. Election of Directors: Rupert Vessey

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 134,555,098AGAINST: 7,335,534

BIO-TECHNE CORP.’s own tally for this item (“Elect Director: Rupert Vessey”): 134,555,098 for, 7,335,534 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 85% for, 5% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 85% of the shares they voted on this item FOR (76,781,624 for, 13,246,487 against).

FOR 85%AGAINST 15%
FOR: 76,781,624 (85.3%)AGAINST: 13,246,487 (14.7%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “Election of Directors: Rupert Vessey” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree32,62611,058,577 00Against
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.1,476,4030 00For
Charles Schwab01,400,493 00Against
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon641,64536,926 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

13. To set the number of Directors at nine.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 141,242,833AGAINST: 672,919

BIO-TECHNE CORP.’s own tally for this item (“Proposal 1: The shareholders voted to set the number of directors at nine:”): 141,242,833 for, 672,919 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 89% for, 0.5% against (90% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (90,023,876 for, 4,235 against).

FOR 99.9%
FOR: 90,023,876 (100.0%)AGAINST: 4,235 (0.0%)ABSTAIN: 11,964 (0.0%)
Largest asset managers voting on “To set the number of Directors at nine.” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.1,476,4030 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

14. Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2024 fiscal year.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 140,734,676AGAINST: 5,247,721

BIO-TECHNE CORP.’s own tally for this item (“Proposal 5: The shareholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024.”): 140,734,676 for, 5,247,721 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 89% for, 3% against (92% of the company cast a for/against vote).

The 150 asset managers below cast 99.9% of the shares they voted on this item FOR (90,027,553 for, 3,704 against).

FOR 99.9%
FOR: 90,027,553 (100.0%)AGAINST: 3,704 (0.0%)ABSTAIN: 8,818 (0.0%)
Largest asset managers voting on “Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 202” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard19,242,5220 00For
WisdomTree11,091,2030 00For
BlackRock9,533,6840 00For
Fidelity5,298,7530 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)4,464,9440 00For
T. Rowe Price2,908,7370 00For
Neuberger Berman2,350,5230 00For
Columbia Threadneedle2,340,3990 00For
TRUST FOR PROFESSIONAL MANAGERS1,933,8000 00For
Brown Capital Management Mutual Funds1,843,6540 00For
Eaton Vance1,746,6960 00For
State Street1,608,4050 00For
Invesco1,553,2200 00For
Ownership Capital B.V.1,476,4030 00For
Charles Schwab1,400,4930 00For
Hartford1,393,9660 00For
Advisors' Inner Circle Fund II1,350,0000 00For
Thrivent1,293,2010 00For
Waddell & Reed1,256,3130 00For
American Century1,169,6300 00For
JANUS INVESTMENT FUND878,9560 00For
ALGER FUNDS735,7940 00For
BNY Mellon678,5710 00For
Allspring632,9960 00For
First Trust590,9950 00For

Showing the 25 largest of 150 asset managers. See all 150 in the interactive database.

15. ADVISORY VOTE ON SAY ON PAY FREQUENCY

COMPENSATION

98% fund support · no official result

FOR 57%ONE YEAR 37%

The 21 asset managers below cast 98% of the shares they voted on this item FOR (1,530,386 for, 24,600 against).

FOR: 1,530,386 (57.4%)AGAINST: 24,600 (0.9%)ONE YEAR: 977,160 (36.6%)1-YEAR: 129,585 (4.9%)1 YEAR: 3,168 (0.1%)THREE YEARS: 1,580 (0.1%)
Largest asset managers voting on “ADVISORY VOTE ON SAY ON PAY FREQUENCY” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.1,476,4030 00For
JPMorgan00 00One Year
Eversept Partners, LP00 00One Year
APG Asset Management US Inc.00 00One Year
ADAGE CAPITAL PARTNERS GP, L.L.C.00 001-Year
TD ASSET MANAGEMENT INC00 00One Year
BEACON INVESTMENT ADVISORY SERVICES, INC.37,2310 00For
Tredje AP-fonden00 00One Year
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND024,600 00Against
Desjardins Global Asset Management Inc.00 00One Year
Empower00 00One Year
NORDEA INVESTMENT MANAGEMENT AB10,3600 00For
Coyle Financial Counsel LLC6,3920 00For
OSSIAM00 00One Year
Sepio Capital, LP00 001 Year
Brighthouse00 00One Year
Symmetry Panoramic Trust00 00Three Years
Regime de rentes du Mouvement Desjardins00 00One Year
Qtron Investments LLC00 001-Year
Echo Street Capital Management LLC00 00One Year
OARSMAN CAPITAL, INC.00 00--

16. ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION

COMPENSATIONMajority of the votes cast: no

35% Majority: no · of votes cast

FOR 35%AGAINST 65%
FOR: 49,894,295AGAINST: 91,277,734

BIO-TECHNE CORP.’s own tally for this item (“Proposal 3: The shareholders voted against a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 49,894,295 for, 91,277,734 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 32% for, 58% against (89% of the company cast a for/against vote).

The 20 asset managers below cast 13% of the shares they voted on this item FOR (337,789 for, 2,286,492 against).

13%AGAINST 87%
FOR: 337,789 (12.9%)AGAINST: 2,286,492 (87.1%)
Largest asset managers voting on “ADVISORY VOTE TO RATIFY NAMED EXECUTIVE OFFICERS' COMPENSATION” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Ownership Capital B.V.01,476,403 00Against
JPMorgan0382,466 00Against
Eversept Partners, LP313,0320 00For
APG Asset Management US Inc.0135,335 00Against
ADAGE CAPITAL PARTNERS GP, L.L.C.0129,386 00Against
TD ASSET MANAGEMENT INC068,562 00Against
Tredje AP-fonden027,895 00Against
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND24,6000 00For
Desjardins Global Asset Management Inc.023,964 00Against
Empower017,222 00Against
NORDEA INVESTMENT MANAGEMENT AB010,360 00Against
OSSIAM05,463 00Against
Union Investment Privatfonds GmbH04,577 00Against
Brighthouse02,744 00Against
Symmetry Panoramic Trust01,580 00Against
Regime de rentes du Mouvement Desjardins0320 00Against
Qtron Investments LLC0199 00Against
Echo Street Capital Management LLC1570 00For
Fiera Capital Corp016 00Against
OARSMAN CAPITAL, INC.00 00--

17. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: no

Combines 4 wordings of this item as funds reported it.

35% Majority: no · of votes cast

FOR 35%AGAINST 65%
FOR: 49,894,295AGAINST: 91,277,734

BIO-TECHNE CORP.’s own tally for this item (“Proposal 3: The shareholders voted against a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 49,894,295 for, 91,277,734 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 32% for, 58% against (89% of the company cast a for/against vote).

The 8 asset managers below cast 2% of the shares they voted on this item FOR (3,085 for, 156,315 against).

AGAINST 98%
FOR: 3,085 (1.9%)AGAINST: 156,315 (98.1%)
Largest asset managers voting on “14A Executive Compensation” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Summit Creek Advisors LLC079,035 00Against
Granite Investment Partners, LLC077,280 00Against
NAPLES GLOBAL ADVISORS, LLC2,3000 00For
BALLAST ADVISORS LLC4000 00For
Glaxis Capital Management, LLC3400 00For
Parisi Gray Wealth Management450 00For
Moisand Fitzgerald Tamayo, LLC00 00--
Port Capital LLC00 00--

18. 14A Executive Compensation Vote Frequency

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

ONE YEAR 50.4%1 YEAR 49.6%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 79,035 (50.4%)1 YEAR: 77,680 (49.6%)
Largest asset managers voting on “14A Executive Compensation Vote Frequency” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Summit Creek Advisors LLC00 00One Year
Granite Investment Partners, LLC00 001 Year
BALLAST ADVISORS LLC00 001 Year
Port Capital LLC00 00--

19. Approve on an advisory basis the frequency of advisory votes on executive compensation

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

— fund support · no official result

1-YEAR 100%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1-YEAR: 16 (100.0%)
Largest asset managers voting on “Approve on an advisory basis the frequency of advisory votes on executive compensation” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fiera Capital Corp00 001-Year
IPConcept (Luxemburg) S.A.00 00--

20. Approve, on an advisory basis, the H of our executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: no

35% Majority: no · of votes cast

FOR 35%AGAINST 65%
FOR: 49,894,295AGAINST: 91,277,734

BIO-TECHNE CORP.’s own tally for this item (“Proposal 3: The shareholders voted against a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement:”): 49,894,295 for, 91,277,734 against, per its Form 8-K filed 2023-10-31 (Item 5.07). FOR was not more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 158,354,579 outstanding shares: 32% for, 58% against (89% of the company cast a for/against vote).

The 1 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 12,698 against).

AGAINST 100%
AGAINST: 12,698 (100.0%)
Largest asset managers voting on “Approve, on an advisory basis, the H of our executive officers.” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Grandeur Peak Global Trust012,698 00Against

21. Approve, on an advisory bass, the frequency of advisory votes on executive H to occur every (1) year.

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 1 asset managers below cast 100% of the shares they voted on this item FOR (12,698 for, 0 against).

FOR: 12,698 (100.0%)
Largest asset managers voting on “Approve, on an advisory bass, the frequency of advisory votes on executive H to occur every (1) year.” at BIO-TECHNE CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Grandeur Peak Global Trust12,6980 00For

Largest BIO-TECHNE CORP. shareholders voting in 2023-2024

Ranked by the number of BIO-TECHNE CORP. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 158,354,579 shares outstanding at the time of that meeting.

Top BIO-TECHNE CORP. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 12.57%
2BlackRock 9.16%
3WisdomTree 7.00%
4Lazard 6.95%
5Fidelity 4.52%
6T. Rowe Price 4.29%
7Neuberger Berman 3.84%
8State Street 3.41%
9BAMCO INC /NY/ 3.11%
10Select Equity Group, L.P. 2.85%

Reported BIO-TECHNE CORP. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

BIO-TECHNE CORP. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
Malvern 11.44% DEF14A
Vanguard Group 11.32% 13F
New 9.35% DEF14A
BlackRock 7.51% 13F
Baltimore 5.38% DEF14A
Morgan Stanley 4.57% 13F
State Street 4.02% 13F
T. Rowe Price 3.63% 13F
Geode Capital 2.42% 13F
Invesco 1.97% 13F

Percentages above are of 158,354,579 shares outstanding, as reported by BIO-TECHNE CORP. on its Form 10-Q dated 2023-09-30 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIO-TECHNE CORP.’s 10-Q dated 2023-09-30. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At BIO-TECHNE CORP.'s shareholder meeting held 2023-10-26, in the 2023-2024 proxy season, 580 asset managers reported how they voted in their SEC Form N-PX filings, covering 9,774 separate fund positions. Their filings are grouped here into 21 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR EXECUTIVE OFFICERS. — FOR was 35% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is not more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BIO-TECHNE CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2023-10-31.

BIO-TECHNE CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.